Position in ARDX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,175,938
+$226,896 QoQ
Shares Held
196,317
+20.6% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. ARDX ranks #30 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,568,627 | $67,278,411 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
627,699 | $35,458,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,977 | $33,926,767 | |
| 4 | RPRX |
Royalty Pharma plc
|
499,167 | $23,945,040 | |
| 5 | TECH |
BIO-TECHNE Corp
|
302,934 | $15,831,330 | |
| 6 | ARGX |
Argenx SE
|
12,682 | $9,261,030 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,470 | $6,772,908 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,440 | $6,521,080 |
All Filings in ARDX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,175,938 | 196,317 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $949,042 | 162,786 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $861,918 | 156,428 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $805,340 | 205,444 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $2,124,090 | 432,605 | Shares | Defined | 2025-08-26 | |
| 2021-06-30 | $14,522,839 | 1,915,942 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $16,119,229 | 2,434,929 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,421,464 | 2,074,415 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||